Dexamethasone stimulates store-operated calcium entry and protein degradation in cultured L6 myotubes through a phospholipase a 2-dependent mechanism

Kiyoshi Itagaki, Michael Menconi, Bozena Antoniu, Qin Zhang, Patricia Gonnella, David Soybel, Carl Hauser, Per Olof Hasselgren

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Muscle wasting in various catabolic conditions is at least in part regulated by glucocorticoids. Increased calcium levels have been reported in atrophying muscle. Mechanisms regulating calcium homeostasis in muscle wasting, in particular the role of glucocorticoids, are poorly understood. Here we tested the hypothesis that glucocorticoids increase intracellular calcium concentrations in skeletal muscle and stimulate store-operated calcium entry (SOCE) and that these effects of glucocorticoids may at least in part be responsible for glucocorticoid-induced protein degradation. Treatment of cultured myotubes with dexamethasone, a frequently used in vitro model of muscle wasting, resulted in increased intracellular calcium concentrations determined by fura-2 AM fluorescence measurements. When SOCE was measured by using calcium "add-back" to muscle cells after depletion of intracellular calcium stores, results showed that SOCE was increased 15-25% by dexamethasone and that this response to dexamethasone was inhibited by the store-operated calcium channel blocker BTP2. Dexamethasone treatment stimulated the activity of calcium-independent phospholipase A2 (iPLA2), and dexamethasone-induced increase in SOCE was reduced by the iPLA2 inhibitor bromoenol lactone (BEL). In additional experiments, treatment of myotubes with the store-operated calcium channel inhibitor gadolinium ion or BEL reduced dexamethasone-induced increase in protein degradation. Taken together, the results suggest that glucocorticoids increase calcium concentrations in myocytes and stimulate iPLA2-dependent SOCE and that glucocorticoid-induced muscle protein degradation may at least in part be regulated by increased iPLA2 activity, SOCE, and cellular calcium levels.

Original languageEnglish (US)
Pages (from-to)C1127-C1139
JournalAmerican Journal of Physiology - Cell Physiology
Volume298
Issue number5
DOIs
StatePublished - May 1 2010

Fingerprint

Phospholipases
Skeletal Muscle Fibers
Dexamethasone
Proteolysis
Calcium
Glucocorticoids
Muscles
Phospholipases A2
Muscle Cells
Calcium-Independent Phospholipase A2
Back Muscles
Muscle Proteins
Fura-2
Gadolinium
Calcium Channel Blockers
Calcium Channels
Skeletal Muscle

All Science Journal Classification (ASJC) codes

  • Physiology
  • Cell Biology

Cite this

Itagaki, Kiyoshi ; Menconi, Michael ; Antoniu, Bozena ; Zhang, Qin ; Gonnella, Patricia ; Soybel, David ; Hauser, Carl ; Hasselgren, Per Olof. / Dexamethasone stimulates store-operated calcium entry and protein degradation in cultured L6 myotubes through a phospholipase a 2-dependent mechanism. In: American Journal of Physiology - Cell Physiology. 2010 ; Vol. 298, No. 5. pp. C1127-C1139.
@article{5268684a41bb49738eedfc1975908959,
title = "Dexamethasone stimulates store-operated calcium entry and protein degradation in cultured L6 myotubes through a phospholipase a 2-dependent mechanism",
abstract = "Muscle wasting in various catabolic conditions is at least in part regulated by glucocorticoids. Increased calcium levels have been reported in atrophying muscle. Mechanisms regulating calcium homeostasis in muscle wasting, in particular the role of glucocorticoids, are poorly understood. Here we tested the hypothesis that glucocorticoids increase intracellular calcium concentrations in skeletal muscle and stimulate store-operated calcium entry (SOCE) and that these effects of glucocorticoids may at least in part be responsible for glucocorticoid-induced protein degradation. Treatment of cultured myotubes with dexamethasone, a frequently used in vitro model of muscle wasting, resulted in increased intracellular calcium concentrations determined by fura-2 AM fluorescence measurements. When SOCE was measured by using calcium {"}add-back{"} to muscle cells after depletion of intracellular calcium stores, results showed that SOCE was increased 15-25{\%} by dexamethasone and that this response to dexamethasone was inhibited by the store-operated calcium channel blocker BTP2. Dexamethasone treatment stimulated the activity of calcium-independent phospholipase A2 (iPLA2), and dexamethasone-induced increase in SOCE was reduced by the iPLA2 inhibitor bromoenol lactone (BEL). In additional experiments, treatment of myotubes with the store-operated calcium channel inhibitor gadolinium ion or BEL reduced dexamethasone-induced increase in protein degradation. Taken together, the results suggest that glucocorticoids increase calcium concentrations in myocytes and stimulate iPLA2-dependent SOCE and that glucocorticoid-induced muscle protein degradation may at least in part be regulated by increased iPLA2 activity, SOCE, and cellular calcium levels.",
author = "Kiyoshi Itagaki and Michael Menconi and Bozena Antoniu and Qin Zhang and Patricia Gonnella and David Soybel and Carl Hauser and Hasselgren, {Per Olof}",
year = "2010",
month = "5",
day = "1",
doi = "10.1152/ajpcell.00309.2009",
language = "English (US)",
volume = "298",
pages = "C1127--C1139",
journal = "American Journal of Physiology",
issn = "0363-6143",
publisher = "American Physiological Society",
number = "5",

}

Dexamethasone stimulates store-operated calcium entry and protein degradation in cultured L6 myotubes through a phospholipase a 2-dependent mechanism. / Itagaki, Kiyoshi; Menconi, Michael; Antoniu, Bozena; Zhang, Qin; Gonnella, Patricia; Soybel, David; Hauser, Carl; Hasselgren, Per Olof.

In: American Journal of Physiology - Cell Physiology, Vol. 298, No. 5, 01.05.2010, p. C1127-C1139.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Dexamethasone stimulates store-operated calcium entry and protein degradation in cultured L6 myotubes through a phospholipase a 2-dependent mechanism

AU - Itagaki, Kiyoshi

AU - Menconi, Michael

AU - Antoniu, Bozena

AU - Zhang, Qin

AU - Gonnella, Patricia

AU - Soybel, David

AU - Hauser, Carl

AU - Hasselgren, Per Olof

PY - 2010/5/1

Y1 - 2010/5/1

N2 - Muscle wasting in various catabolic conditions is at least in part regulated by glucocorticoids. Increased calcium levels have been reported in atrophying muscle. Mechanisms regulating calcium homeostasis in muscle wasting, in particular the role of glucocorticoids, are poorly understood. Here we tested the hypothesis that glucocorticoids increase intracellular calcium concentrations in skeletal muscle and stimulate store-operated calcium entry (SOCE) and that these effects of glucocorticoids may at least in part be responsible for glucocorticoid-induced protein degradation. Treatment of cultured myotubes with dexamethasone, a frequently used in vitro model of muscle wasting, resulted in increased intracellular calcium concentrations determined by fura-2 AM fluorescence measurements. When SOCE was measured by using calcium "add-back" to muscle cells after depletion of intracellular calcium stores, results showed that SOCE was increased 15-25% by dexamethasone and that this response to dexamethasone was inhibited by the store-operated calcium channel blocker BTP2. Dexamethasone treatment stimulated the activity of calcium-independent phospholipase A2 (iPLA2), and dexamethasone-induced increase in SOCE was reduced by the iPLA2 inhibitor bromoenol lactone (BEL). In additional experiments, treatment of myotubes with the store-operated calcium channel inhibitor gadolinium ion or BEL reduced dexamethasone-induced increase in protein degradation. Taken together, the results suggest that glucocorticoids increase calcium concentrations in myocytes and stimulate iPLA2-dependent SOCE and that glucocorticoid-induced muscle protein degradation may at least in part be regulated by increased iPLA2 activity, SOCE, and cellular calcium levels.

AB - Muscle wasting in various catabolic conditions is at least in part regulated by glucocorticoids. Increased calcium levels have been reported in atrophying muscle. Mechanisms regulating calcium homeostasis in muscle wasting, in particular the role of glucocorticoids, are poorly understood. Here we tested the hypothesis that glucocorticoids increase intracellular calcium concentrations in skeletal muscle and stimulate store-operated calcium entry (SOCE) and that these effects of glucocorticoids may at least in part be responsible for glucocorticoid-induced protein degradation. Treatment of cultured myotubes with dexamethasone, a frequently used in vitro model of muscle wasting, resulted in increased intracellular calcium concentrations determined by fura-2 AM fluorescence measurements. When SOCE was measured by using calcium "add-back" to muscle cells after depletion of intracellular calcium stores, results showed that SOCE was increased 15-25% by dexamethasone and that this response to dexamethasone was inhibited by the store-operated calcium channel blocker BTP2. Dexamethasone treatment stimulated the activity of calcium-independent phospholipase A2 (iPLA2), and dexamethasone-induced increase in SOCE was reduced by the iPLA2 inhibitor bromoenol lactone (BEL). In additional experiments, treatment of myotubes with the store-operated calcium channel inhibitor gadolinium ion or BEL reduced dexamethasone-induced increase in protein degradation. Taken together, the results suggest that glucocorticoids increase calcium concentrations in myocytes and stimulate iPLA2-dependent SOCE and that glucocorticoid-induced muscle protein degradation may at least in part be regulated by increased iPLA2 activity, SOCE, and cellular calcium levels.

UR - http://www.scopus.com/inward/record.url?scp=77951487470&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951487470&partnerID=8YFLogxK

U2 - 10.1152/ajpcell.00309.2009

DO - 10.1152/ajpcell.00309.2009

M3 - Article

C2 - 20107037

AN - SCOPUS:77951487470

VL - 298

SP - C1127-C1139

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6143

IS - 5

ER -